Evidence map›Paper›PMID 40974867›Full record

ArticleOral oncology2025

Uncovering chromatin factor landscapes in head and neck squamous cell carcinoma.

Hui Cheng, Meiye Jiang, Sohyoung Kim, Arfa Moshiri, Mohd Saleem Dar, Jawad Akhtar, Vassiliki Saloura

Abstract read
In one paragraph

Article in Oral oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hui ChengHead and Neck Surgery Branch, National Institutes of Deafness and Communication Disorders, NIDCD, NIH, United States.
Meiye JiangThoracic and Gl Malignancies Branch, Center for Cancer Research, National Cancer Institute, United States.
Sohyoung KimLaboratory of Gene Expression and Nuclear Receptor Biology, Center for Cancer Research, National Cancer Institute, United States.
Arfa MoshiriThoracic and Gl Malignancies Branch, Center for Cancer Research, National Cancer Institute, United States.
Mohd Saleem DarThoracic and Gl Malignancies Branch, Center for Cancer Research, National Cancer Institute, United States.
Jawad AkhtarThoracic and Gl Malignancies Branch, Center for Cancer Research, National Cancer Institute, United States.
Vassiliki SalouraThoracic and Gl Malignancies Branch, Center for Cancer Research, National Cancer Institute, United States. Electronic address: vassiliki.saloura@nih.gov.

Funding

The Role of WHSC1L1 in Squamous Cell Carcinoma of the Head and NeckZIABC011831 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SALOURA, VASSILIKI · 2018 to 2025
$7.6M
Intramural NIH HHS ZIA BC011831
6 · The paper itself

Abstract

Chromatin factors, defined here as proteins that chemically modify the DNA and histones, remodel chromatin and regulate nucleosome occupancy, play central roles in the transcriptional regulation of genes and are implicated in cancer initiation and progression in multiple cancer types. To systematically investigate the genomic and expression alterations of chromatin factors in head and neck squamous cell carcinoma (HNSCC), we utilized the molecular profiles from 530 HNSCC tumor samples in the Cancer Genome Atlas (TCGA), and characterized the mutational, copy number and transcriptional alterations of 422 chromatin factors, as well as their correlation with the "cold" tumor phenotype in HPV-negative and HPV-positive HNSCC. Histone-lysine N-methyltransferase 2D (MLL2) was the most frequently mutated chromatin factor in both HPV-negative and HPV-positive HNSCC, with mutation frequencies of 12-17 %. Actin Like 6A (ACTL6A), a component of the SWI/SNF chromatin remodeling complex, was the most frequently copy-number amplified chromatin factor in both HPV-negative and HPV-positive HNSCC, with amplification frequencies of 19-24 %. Double PHD Fingers 1 (DPF1), a component of the chromatin remodeling complex, and Ubiquitin Like With PHD AndRing Finger Domains1 (UHRF1) were the most overexpressed chromatin factors in HPV-negative and HPV-positive HNSCC tumors respectively. Components of the chromatin remodeling complex, such as ACTL6A, SMARCA1 and MORF4L2, were correlated with the "cold" tumor phenotype in both HPV-negative and HPV-positive HNSCC. This brief study highlights epigenetic chromatin factors that may drive oncogenesis and immune evasion, thereby identifying novel targets for cancer therapy in clearly defined, epigenetically-driven subtypes of HPV-negative and HPV-positive HNSCC.

Indexed as

ChromatinHead and Neck NeoplasmsSquamous Cell Carcinoma of Head and NeckDNA Copy Number VariationsFemaleGene Expression Regulation, NeoplasticHumansMaleMutationTranscription FactorsChromatinTranscription FactorsChromatin factorsHead and neck cancerSquamous cell carcinoma

Identifiers

PMID40974867
PMCPMC12674457

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.